PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells (original) (raw)

• Barbieri CE, Barton CE, Pietenpol JA . (2003). Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. J Biol Chem 278: 51408–51414.
  Article CAS Google Scholar
• Barbieri CE, Pietenpol JA . (2006). p63 and epithelial biology. Exp Cell Res 312: 695–706.
  Article CAS Google Scholar
• Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567–578.
  Article CAS Google Scholar
• Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L et al. (1999). Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104: 263–269.
  Article CAS Google Scholar
• Choong NW, Cohen EE . (2006). Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 57: 25–43.
  Article Google Scholar
• Chun PY, Feng FY, Scheurer AM, Davis MA, Lawrence TS, Nyati MK . (2006). Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. Cancer Res 66: 981–988.
  Article CAS Google Scholar
• Citri A, Yarden Y . (2006). EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505–516.
  Article CAS Google Scholar
• Costa DB, Halmos B, Kumar A, Schumer ST, Huberman MS, Boggon TJ et al. (2007). BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS Med 4: 1669–1679; discussion 1680.
  Article CAS Google Scholar
• Cragg MS, Kuroda J, Puthalakath H, Huang DC, Strasser A . (2007). Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med 4: 1681–1689; discussion 1690.
  Article CAS Google Scholar
• Gong Y, Somwar R, Politi K, Balak M, Chmielecki J, Jiang X et al. (2007). Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas. PLoS Med 4: e294.
  Article Google Scholar
• Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57–70.
  Article CAS Google Scholar
• Huang C, Schmid PC, Ma WY, Schmid HH, Dong Z . (1997). Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J Biol Chem 272: 4187–4194.
  Article CAS Google Scholar
• Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. (2003). Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321–328.
  Article CAS Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43–66.
  Article Google Scholar
• Kalyankrishna S, Grandis JR . (2006). Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24: 2666–2672.
  Article CAS Google Scholar
• Karst AM, Dai DL, Martinka M, Li G . (2005). PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24: 1111–1116.
  Article CAS Google Scholar
• Kitada S, Leone M, Sareth S, Zhai D, Reed JC, Pellecchia M . (2003). Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 46: 4259–4264.
  Article CAS Google Scholar
• Labi V, Erlacher M, Kiessling S, Villunger A . (2006). BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13: 1325–1338.
  Article CAS Google Scholar
• Liu B, Fang M, Schmidt M, Lu Y, Mendelsohn J, Fan Z . (2000). Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer 82: 1991–1999.
  Article CAS Google Scholar
• Matheny KE, Barbieri CE, Sniezek JC, Arteaga CL, Pietenpol JA . (2003). Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 113: 936–939.
  Article CAS Google Scholar
• Ming L, Sakaida T, Yue W, Jha A, Zhang L, Yu J . (2008). Sp1 and p73 Activate PUMA Following Serum Starvation. Carcinogenesis 29: 1878–1884.
  Article CAS Google Scholar
• Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM et al. (2008). Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 113: 97–107.
  Article CAS Google Scholar
• Nakano K, Vousden KH . (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683–694.
  Article CAS Google Scholar
• Oliver CL, Bauer JA, Wolter KG, Ubell ML, Narayan A, O’Connell KM et al. (2004). in vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells. Clin Cancer Res 10: 7757–7763.
  Article CAS Google Scholar
• Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B . (1994). Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 54: 3714–3717.
  CAS PubMed Google Scholar
• Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP et al. (2008). PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2: 576–583.
  Article CAS Google Scholar
• Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW . (2006). p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45–56.
  Article CAS Google Scholar
• She QB, Solit DB, Ye Q, O’Reilly KE, Lobo J, Rosen N . (2005). The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8: 287–297.
  Article CAS Google Scholar
• Sordella R, Bell DW, Haber DA, Settleman J . (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163–1167.
  Article CAS Google Scholar
• Sun Q, Sakaida T, Yue W, Gollin SM, Yu J . (2007). Chemosensitization of head and neck cancer cells by PUMA. Mol Cancer Ther 6: 3180–3188.
  Article CAS Google Scholar
• Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302: 1036–1038.
  Article CAS Google Scholar
• Wang G, Nikolovska-Coleska Z, Yang CY, Wang R, Tang G, Guo J et al. (2006a). Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 49: 6139–6142.
  Article CAS Google Scholar
• Wang H, Qian H, Yu J, Zhang X, Zhang L, Fu M et al. (2006b). Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther 5: 380–385.
  Article CAS Google Scholar
• Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula SM et al. (2000). Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA 97: 7124–7129.
  Article CAS Google Scholar
• Wang P, Yu J, Zhang L . (2007). The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 104: 4054–4059.
  Article CAS Google Scholar
• Wolter KG, Wang SJ, Henson BS, Wang S, Griffith KA, Kumar B et al. (2006). (−)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia 8: 163–172.
  Article CAS Google Scholar
• Wu B, Qiu W, Wang P, Yu H, Cheng T, Zambetti GP et al. (2007). p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut 56: 645–654.
  Article CAS Google Scholar
• You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M et al. (2006). FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 203: 1657–1663.
  Article CAS Google Scholar
• Yu J, Wang P, Ming L, Wood MA, Zhang L . (2007). SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events. Oncogene 26: 4189–4198.
  Article CAS Google Scholar
• Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L . (2003). PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100: 1931–1936.
  Article CAS Google Scholar
• Yu J, Yue W, Wu B, Zhang L . (2006). PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res 12: 2928–2936.
  Article Google Scholar
• Yu J, Zhang L . (2003). No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4: 248–249.
  Article CAS Google Scholar
• Yu J, Zhang L . (2004). Apoptosis in human cancer cells. Curr Opin Oncol 16: 19–24.
  Article Google Scholar
• Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673–682.
  Article CAS Google Scholar
• Zhang L, Ming L, Yu J . (2007). BH3 mimetics to improve cancer therapy; mechanisms and examples. Drug Resist Updat 10: 207–217.
  Article CAS Google Scholar